These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10352354)

  • 1. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
    Lapointe N; Chen H; Qi S; Xu D; Daloze P; Dumont L
    Eur Surg Res; 1999; 31(3):259-66. PubMed ID: 10352354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation.
    Dumont L; Chen H; Daloze P; Xu D; Garceau D
    Transplantation; 1993 Jul; 56(1):181-4. PubMed ID: 8333040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
    Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
    Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C; Qiu C; Engels K
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
    Levy AE; Alexander JW
    Transplantation; 1995 Oct; 60(8):812-5. PubMed ID: 7482740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y; Ono H; Frohlich ED
    Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
    Griffin KA; Picken M; Bakris GL; Bidani AK
    Hypertension; 2001 May; 37(5):1268-72. PubMed ID: 11358939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
    Greven J
    Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
    Ma G; Allen TJ; Cooper ME; Cao Z
    Kidney Int; 2004 Sep; 66(3):1090-8. PubMed ID: 15327403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
    Roux S; Bühler M; Clozel JP
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):132-9. PubMed ID: 8656647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model.
    Candinas D; Mark W; Kaever V; Miyatake T; Koyamada N; Hechenleitner P; Hancock WW
    Transplantation; 1996 Dec; 62(12):1855-60. PubMed ID: 8990376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
    Schmitt R; Clozel JP; Iberg N; Bühler FR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
    Matthes J; Huber I; Haaf O; Antepohl W; Striessnig J; Herzig S
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):578-83. PubMed ID: 10882031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.